( OTC-PINK:GTBP, OTC-QB:GTBP, OTC-QX:GTBP, OtherOTC:GTBP )

News from GT Biopharma Inc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Mar 29, 2018, 09:05 ET GT Biopharma Inc. Announces >50% Enrollment in Proof-Of-Concept Clinical Trial For Its Novel Treatment For Motion Sickness

GT Biopharma Inc. (OTCQB: GTBP) (Euronext Paris: GTBP.PA) announced today that the Proof-of-Concept clinical trial with GTP-011, a novel treatment...


Mar 26, 2018, 07:45 ET GT Biopharma, Inc. Announces Additional Positive Data From Its Phase 1 Clinical Trial For Myasthenia Gravis and Potential for Acceleration of the Start of Its Phase 2 Trial

GT Biopharma Inc. (OTCQB "GTBP" and Euronext Paris "GTBP.PA") today announced that it has completed the analysis of pharmacokinetic data...


Mar 13, 2018, 07:30 ET GT Biopharma to Present at Roth Capital Partners 30th Annual Conference

GT Biopharma Inc. (OTCQB: GTBP) (Euronext Paris: GTBP.PA) today announced that Shawn Cross, Chairman and Chief Executive Officer, and Raymond...


Feb 13, 2018, 07:45 ET GT Biopharma Announces Dr. Jeffrey Miller, Renowned NK Cell Cancer Specialist, Will Present at Cell Therapy Symposia

GT Biopharma Inc. (OTCQB: GTBP) (Euronext Paris: GTBP.PA) announced today that Dr. Jeffrey Miller, Deputy Director of the Masonic Cancer Center,...


Jan 24, 2018, 08:39 ET GT Biopharma, Inc. Issues Letter to Shareholders

GT Biopharma Inc. (OTCQB: GTBP) (Euronext Paris: GTBP.PA) today announced that Executive Chairman Anthony Cataldo has issued the following letter...


Jan 23, 2018, 09:10 ET GT Biopharma Announces $7.1 Million Convertible Debt Financing

GT Biopharma Inc. (OTCQB: GTBP and Euronext Paris: GTBP.PA) today announced that it has entered into definitive agreements for a private placement...


Jan 16, 2018, 08:30 ET Geoffrey B. Davis Joins GT Biopharma's Board of Directors

GT Biopharma Inc. (OTCQB: GTBP) and (Euronext Paris: GTBP.PA) today announced that Geoffrey B. Davis will join GT Biopharma's Board of Directors...


Jan 09, 2018, 07:45 ET GT Biopharma Announces Completion of Dosing in Phase 1 Clinical Trial of GTP-004 for Myasthenia Gravis

GT Biopharma Inc. (OTCQB: GTBP) and (Euronext Paris: GTBP.PA) today announced that it has completed dosing in its Phase 1 clinical trial for...


Dec 18, 2017, 10:27 ET GT Biopharma, Inc. Files Application for NASDAQ Capital Market Listing

GT Biopharma Inc. (GTBP) today announced that the Company has filed an application to list its common stock on the NASDAQ Capital Market. GT...